SAN FRANCISCO, April 15, 2020 /PRNewswire/ -- The global patient registry software market size is expected to reach USD 2.3 billion by 2027, expanding at a CAGR of 11.7%, according to a new report by Grand View Research, Inc. Increasing demand for integrated healthcare systems is fueling the demand for patient registry software. Surmounting burden to curb the healthcare cost is expected to fuel market growth via higher penetration and untapped opportunities. Lack of patient information access was found to be a major barrier for integrating care and proper treatment option in both developed and developing countries, which is further driving the market.

Key suggestions from the report:

• Disease registry held the largest revenue share in the patient registry software market owing to the increasing demand to curb the disease burden and stringent regulations by the government bodies
• The standalone segment held the largest share in 2019 and is expected to witness a CAGR of over 11.0% by 2027. The growth can be attributed to advanced features offered by the software such as easy data retrieval and auto upgradation
• The on-premise segment held the largest revenue share in 2019. This is due to enhanced data security options and ease of access
• The public database type segment is expected to show the fastest growth over the forecast period owing to its increased usage for research purposes
• The population health management segment held the largest revenue share in 2019. This is due to its growing adoption in developed countries for better patient care
• The pharma and medical device companies segment is expected to show the fastest growth over the forecast period, owing to the increasing use of registries by these companies for clinical trial enrollment
• Asia Pacific is expected to emerge as the fastest-growing region in this space. Moreover, North America held the largest revenue share due to its established healthcare structure and stringent regulations by the government bodies
• Some of the major players include IBM; IQVIA; Elekta AB; McKesson Corporation; Dacima Software Inc.; Phytel, Inc.

Read 120 page research report with ToC on "Patient Registry Software Market Size, Share & Trends Analysis Report By Product, By Software (Standalone, Integrated), By Deployment Model, By Database Type, By Functionality, By End Use, By Region, And Segment Forecasts, 2020 - 2027'' at: https://www.grandviewresearch.com/industry-analysis/patient-registry-software-market

Increasing number of clinical trials by major pharmaceutical and biotechnological companies is expected to drive the patient registry software market over the forecast period. The data obtained via patient registry software helps in tracking patients for clinical trials. Moreover, associated advantages such as increased cost-effectiveness, efficient resource management, and reduced healthcare IT cost, are further widening the scope for market growth. The industry players are also constantly trying to develop advanced registries which can be easily integrated with national registries for a better outcome.

For instance, in September 2019, Elekta signed a distribution agreement with DocSoft for the key patient-specific QA solution software namely EPIgray, MU2Net, and EPIbeam. These software will help to analyze the treatment plan for any diagnosed condition, for future purposes. This agreement is expected to increase the company's market penetration in the coming years. 

Grand View Research has segmented the global patient registry software market based on product, software, database type, deployment model, functionality, end use, and region:

• Patient Registry Software Product Outlook (Revenue, USD Million, 2016 - 2027)
• Disease Registry
• Cardiovascular
• Diabetes
• Cancer
• Rare disease
• Asthma
• Others
• Health Service Registry
• Product Registry
• Medical Device
• Drug
• Patient Registry Software Outlook (Revenue, USD Million, 2016 - 2027)
• Standalone
• Integrated
• Patient Registry Software Deployment Model Outlook (Revenue, USD Million, 2016 - 2027)
• On Premise
• Web/Cloud based
• Patient Registry Software Database Type Outlook (Revenue, USD Million, 2016 - 2027)
• Commercial
• Public
• Patient Registry Software Functionality Outlook (Revenue, USD Million, 2016 - 2027)
• Population Health Management
• Health Information Exchange
• Patient Care Management
• Point-Of-Care
• Medical Research & Clinical Studies
• Product Outcome Evaluation
• Patient Registry Software End-use Outlook (Revenue, USD Million, 2016 - 2027)
• Government & Third Party
• Hospitals & Medical Practices
• Private Payers
• Pharma & Medical Device Companies
• Research Organization
• Patient Registry Software Regional Outlook (Revenue, USD Million, 2016 - 2027)
• North America
• U.S.
• Canada
• Europe
• U.K.
• Germany
• France
• Italy
• Spain
• Sweden
• Asia Pacific
• Japan
• China
• India
• Australia
• Singapore
• South Korea
• Latin America
• Brazil
• Mexico
• Argentina
• Middle East & Africa
• South Africa
• Saudi Arabia

Find more research reports on Healthcare IT Industry, by Grand View Research:

Gain access to Grand View Compass, our BI enabled intuitive market research database of 10,000+ reports

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: +1-415-349-0058
Toll Free: 1-888-202-9519
Email: [email protected] 
Web: https://www.grandviewresearch.com 
Follow Us: LinkedIn | Twitter

SOURCE Grand View Research, Inc.